Skip to content Skip to footer
Subscribe Now
NEWS

Tenaya Therapeutics and Alnylam Pharmaceuticals Partner to Discover Novel Genetic Targets for CV Therapies in ~$1.13B Deal

Shots: Tenaya has entered into a research collaboration with Alnylam to identify novel human genetic targets that could enable the development of disease-modifying therapies for cardiovascular (CV) diseases Under the collaboration, Tenaya will validate up to 15 gene targets, while Alnylam will lead all the development & commercialization of therapies arising from these validated targets…
March 6, 2026

Read more

VIEWPOINTS_Andrea Mugan_2023
VIEWPOINTS

Andrea Mugan, Global Franchise Head of DDR & GYN/GU Cancers, AstraZeneca Shares Insights on ‘Never Miss’ campaign

Shots: Andrea briefed PharmaShots about the global prostate cancer awareness ‘Never Miss’ campaign developed by AstraZeneca and MSD to help men understand their potential risk of developing prostate cancer He also talked about the increasing number of prostate cancer patients and how this campaign will help support those who may be impacted by prostate cancer…
June 22, 2023

Read more

Thoughtspot_Haikle_lee_2023
THOUGHTSPOT

Understanding Selective Hearing Loss: Symptoms, Causes, and Treatment

Selective hearing loss, also known as selective auditory attention, is a condition in which an individual has difficulty hearing specific sounds or conversations, while still being able to hear other sounds normally. This type of hearing loss can cause significant communication problems, particularly in noisy environments, and can affect an individual's personal and professional life.…
May 19, 2023

Read more